🇺🇸 FDA
Patent

US 7115739

Triazole compounds useful as protein kinase inhibitors

granted A61PA61P1/16A61P11/06

Quick answer

US patent 7115739 (Triazole compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/16, A61P11/06, A61P17/06, A61P19/00